A randomized prospective cross-over study of highly purified follicle- stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years

Journal of Assisted Reproduction and Genetics

Volumn 17, Issue 2, 2000, Pages 107-112

  Bassil, S ^a   Wyns, C ^b   Donnez, J ^b  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Cross over; FSH; HMG; IVF

Indexed keywords

FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; UROFOLLITROPIN;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; EMBRYO TRANSFER; FEMALE; FERTILIZATION; HUMAN; OOCYTE; OVARY CYCLE; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CROSS-OVER STUDIES; DRUG THERAPY, COMBINATION; EMBRYO TRANSFER; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; MENOTROPINS; OOCYTES; OVARY; PROSPECTIVE STUDIES;

FALLOPIA;

EID: 0034000288     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009418017662     Document Type: Conference Paper

References (26)

1. Stanger J, Yovich J: Reduced in vitro fertilization of human ovocyte from patients with raised basal luteinizing hormone levels during the follicular phase. Br J Obstet Gynaecol 1985;92:885-393
2. Daya S, Gunby J, Hughes E, Collins J, Sagle M: Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization. Hum Reprod 1995;10:1392-1396
3. Homburg R, Armar NA, Eshel A, Adams J, Jacobs HJ: Influence of serum luteinising hormone concentration on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br Med J 1988;297:1024-1026
4. Regan L, Owen EJ, Jacobs HS: Hypersecretion of luteinizing hormone, infertility and miscarriage. Lancet 1990;336:1141-1144
5. Rojas F, Moretti-Rojas I, Balmaceda J, Asch R: Delayed occurrence of an LH surge after hCG administration during ovarian stimulation with gonadotropins: Effect of LHRH treatment. Hum Reprod 1989;4:643-646
6. Fleming R, and Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotrophin suppression. Fertil Steril 1986;45:226-230
7. Howles C, MacNamee M, Edwards R: Follicular development and early luteal function of conception and non-conceptual cycles after human in vitro fertilization: endocrine correlates. Hum Reprod 1987;2:17-21
8. Muasher S: Controversies in assisted reproduction: Treatment of low responders. J Assist Reprod Genet 1993;10:112-114
9. Craft: Factors affecting the outcome of assisted conception. Br Med Bull 1990;46:769-782
10. Spandorfer S, Avrech O, Colombero L, Palermo G, Rosenwaks Z: Effect of parental age on fertilization and pregnancy characteristics in couples treated by intracytoplasmic sperm injection. Hum Reprod 1998;13:334-338
11. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP); Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
12. Giudice E, Crisci C, Eshkal A, Papoian R: Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterisation of non-gonadotrophin proteins. Hum Reprod 1994;9:2291-2299
13. Bassil S, Wyns C, Toussaint-Demylle D, Abdelnour W, Donnez J: Predictive factors of multiple pregnancy in in vitro fertilization. J Reprod Medicine 1997;42:761-766
14. Edelstein M, Brzyski, R, Jones R, Simonetti S, Muasher, S: Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gonadotropin-releasing hormone suppression. Fertil Steril 1990;53:103-106
15. Tanbo T, Dale PO, Ejekshus E, Haring E, Abyholm T: Stimulation with human menopausal gonadotropin versus follicle stimulating hormone after pituitary suppression in polycystic ovarian syndrome. Fertile Steril 1990;53:798-803
16. Westergaard L, Erb K, Laursen S, Rasmussen P, Rex S: The effect of human menopausal gonadotrophin and highly purified, urine-derived stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod 1996;11:1209-1213
17. Daya S, Gunby J, Hughes E, Collins J, Sagle M: Follicle-stimulating hormone versus human menopausal gonadotrophin for in-vitro fertilization cycles: A meta-analysis. Fertil Steril 1995;64:347-354
18. Balasch J, Fabregues F, Creus M, Moreno V, Puerto B, Penarrubia J, Carmona F, Vanrell JA: Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum Reprod 1996;11:2400-2404
19. Söderström-Antilla V, Foudila T, Hovatta O: A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programme. Hum Reprod 1996;11:1864-1870
20. Diecfalusy E, Harlin J: Clinical-pharmacological studies on human menopausal gonadotrophin. Hum Reprod 1988;3:21-27
21. Fleming R, Chung CC, Yates RW, Coutts JR: Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity. Hum Reprod 1996;11:1854-1858
22. Jacobs HS, Porter R, Eshel A, Craft I: In LHRH and its Analogues: Contraception and Therapeutic Application II. BH Vichery, IJ Nestor (eds), Lancaster, M.T.P. Press, 1987, pp 303-319
23. Scott R, Hofmann G, Oehninger S, Muasher S: Intercycle variability of Day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;54:297-302
24. Staessen C, Nagy ZP, Liu J, Janssenwillen C, Camus M, Devroey P, Van Sterirteghem A: One year's experience with elective transfer of two good quality embryos in the human in-vitro fertilization and intracytoplasmic sperm injection programmes. Hum Reprod 1995;10:3305-3312
25. Khan K, Daya S, Collin J, Walter S: Empirical evidence of bias in infertility research: Overestimation of treatment effect in crossover trials using pregnancy as the outcome measure. Fertil Steril 1996;65:939-945
26. te Velde E, Looman C: Crossover design versus parallel studies in infertility research. Fertil Steril 1998;69:357-358